The digital and health technologies chapter of the Swiss Biotech Association unites members and stakeholders to advance the digital transformation of therapeutic development. We focus on technologies that enable or enhance the discovery, development, delivery, and manufacturing of novel therapeutics.
Digital tools and computational approaches that contribute to:
To support safe, scalable innovation, the chapter also promotes essential enabling systems:
Together, these technologies power precision diagnostics, predictive modeling, treatment optimization, and data-driven clinical decisions – building the foundation for trusted, high-impact digital solutions and strengthening Switzerland’s position as a global leader in biotech innovation.
Engage and partner with the community on our platforms that benefit all Swiss biotech companies. Explore the possibilities and get in touch with us.
Our chapter community will once again have dedicated visibility at the premier global biotechnology conference for life sciences : The Swiss Biotech Day on May 4-5, 2026.
In 2025 it attracted over 3,000 participants from nearly 50 countries. If you are looking to connect, showcase innovation, and explore new partnerships, mark your calendar — dedicated pitch slots and other chapter activities will be announced soon.
Early confirmation of your interest in pitching slots or contributing to the panel discussion ensures smooth coordination and access to tailored visibility opportunities within the chapter program.
This session moderated by Pablo Nieto, Principal, IQVIA, explored how adaptive and autonomous AI models are reshaping healthcare and life sciences. Discussions focused on infrastructure needs to support scalable, high-performance models and data ecosystems, with examples in biomarker discovery, patient data analytics, drug development and diagnostics.
Panelists









The pitching session showcased groundbreaking startups at the interface of AI, data science and therapeutic innovation, reflecting the transformative potential of digital technologies.
— Winner —
JUVION Life Sciences
Revolutionizing aging therapeutics with AI-driven discovery
Pitched by: Jamshid Asadzadeh, CSO & Co-founder
— 2nd place —
AlphaMol Science
Redefining GPCR drug discovery through computational precision
pitched by: Shuguang Yuan, CEO
— 3rd place —
GeneVault
Unlocking diversity in genomic data
pitched by: Vinod Gauba, CEO & Co-founder
inVirtuoLabs
The next generation laboratory for drug design
pitched by: Gianvito Grasso, CEO
Parithera
Data engine to decode tumor heterogeneity
pitched by: Antoine Herzog, CEO
dEEGtal
From clinical epilepsy impact to a universal EEG AI platform
pitched by: Eric Ménétré, CEO
Skyvor Medical
AI-powered platforms to supercharge clinical trials
pitched by: Linus Kao, CE
Presented by:
Supported by: